Yong-xiao Z. Cao
76 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Tussilagone inhibits MRGPRX2-mediated mast cell degranulation and suppresses pseudo-allergic reactions.
Journal: Toxicology and applied pharmacology
Published: December 05, 2025
The effect of evening vs. morning medication on morning blood pressure surge.
Journal: Scientific reports
Published: September 10, 2025
EGFR tyrosine kinase inhibitor ZZC4 overcomes acquired resistance to gefitinib.
Journal: Toxicology and applied pharmacology
Published: December 02, 2024
Novel therapeutic regimens against Helicobacter pylori: an updated systematic review.
Journal: Frontiers in microbiology
Published: April 16, 2024
Ursolic acid attenuates pseudo-allergic reactions via reducing MRGPRX2-mediated mast cell degranulation.
Journal: Immunology letters
Published: March 07, 2024
Sodium sulfite-driven Helicobacter pylori eradication: Unraveling oxygen dynamics through multi-omics investigation.
Journal: Biochemical pharmacology
Published: December 21, 2023
The effects of sodium sulfite on Helicobacter pylori by establishing a hypoxic environment.
Journal: Toxicology and applied pharmacology
Published: April 08, 2023
A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Journal: PloS one
Published: April 11, 2022
Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot.
Journal: BMC anesthesiology
Published: August 15, 2021
Last Updated: 09/26/2026